MC of $150M with the current uptake is fair value and if PCK can capture 50% of the dementia patients in Australia, the MC should be around $200M with the potential global expansion which I think will also be slow (similar to Australia), hence I can't see a MC higher than that. But if Philips deal occurs, easily MC of $500M, however, this is looking less likely so the pps has been dropping.
MC of $150M with the current uptake is fair value and if PCK can...
-
- There are more pages in this discussion • 590 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
